| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/21/2006 | EP1345624B1 Induction of tolerance |
| 06/21/2006 | EP1329221B1 Polymeric micelle containing cisplatin enclosed therein and use thereof |
| 06/21/2006 | EP1305047B1 Non-peptide ccr1 receptor antagonists in combination with cyclosporin a for the treatment of heart transplant rejection |
| 06/21/2006 | EP1267866B1 The treatment of respiratory diseases |
| 06/21/2006 | EP1189931B1 Peptide compounds that bind her2 |
| 06/21/2006 | EP1178816B1 Materials for soft tissue augmentation and methods of making and using same |
| 06/21/2006 | EP1150999B1 Cyclosporin derivatives and method for the production of said derivatives |
| 06/21/2006 | EP1051208B1 Hydrophilic coating for an intracorporeal medical device |
| 06/21/2006 | EP1042363B1 Novel anti-hiv immunogens (toxoids), preparation methods and use for preventing and treating aids |
| 06/21/2006 | EP1007089B1 Anticoagulant humanised antibodies against factor IX, for use in the treatment of thrombosis |
| 06/21/2006 | EP0998941B1 Use of midkine or of anti-midkine antibodies |
| 06/21/2006 | EP0932626B1 G protein-coupled receptor antagonists |
| 06/21/2006 | EP0914342B1 Polymeric somatostatin derivatives useful for promoting body growth |
| 06/21/2006 | EP0912198B1 Immunoliposomes that optimize internalization into target cells |
| 06/21/2006 | EP0909564B1 Erythropoietin solution preparation stabilized with amino acids |
| 06/21/2006 | EP0830456B1 ISOLATED FrpB NUCLEIC ACID MOLECULE AND VACCINE |
| 06/21/2006 | EP0811384B1 Muscle protein decomposition inhibitor containing il-6 receptor antibody |
| 06/21/2006 | EP0754231B1 Peptide fragment of the respiratory syncytial virus g protein, immunogenic agent, pharmaceutical composition containing same, and preparation method |
| 06/21/2006 | EP0723663B1 Hybridoma and anti-kc-4 humanised monoclonal antibody, dna and rna encoding it, kit and diagnostic methods |
| 06/21/2006 | EP0661973B1 Method of preventing nmda receptor complex-mediated neuronal damage |
| 06/21/2006 | CN1791679A Gene therapy vectors having reduced immunogenicity based on CD8 alpha-chain |
| 06/21/2006 | CN1791612A Novel antimicrobial peptides with heparin binding activity |
| 06/21/2006 | CN1791599A 丙型肝炎抑制剂化合物 Hepatitis C inhibitor compounds |
| 06/21/2006 | CN1791425A C1 inhibitor with short half-life for transient treatment |
| 06/21/2006 | CN1791424A Sustained-release fine granular preparation of human growth hormone and process for producing the same |
| 06/21/2006 | CN1791423A Treatment of alzheimer's disease |
| 06/21/2006 | CN1791422A Use of clusterin for the treatment and/or prevention of peripheral neurological diseases |
| 06/21/2006 | CN1791421A Method for inducing mammary epithelial cell differentiation |
| 06/21/2006 | CN1791420A Treatment of T-cell mediated diseases |
| 06/21/2006 | CN1791386A Small-particle pharmaceutical formulations of antiseizure and antidementia agents and immunosuppressive agents |
| 06/21/2006 | CN1789424A Dual target effected chimera recombinant, its construction method and application |
| 06/21/2006 | CN1789411A Isolated nucleic acid molecules which encode T cell inducible factors (TIF), the proteins encoded, and uses thereof |
| 06/21/2006 | CN1789282A Multifunctional polypeptide |
| 06/21/2006 | CN1789279A Inhibitory peptide of YMDD domain of duck hepatitis-B virus polymerase protein and application thereof |
| 06/21/2006 | CN1789278A Osteoporosis resistant estrogen-RGD peptide conjugate and its application in medicine |
| 06/21/2006 | CN1788791A Papain-containing capsule for regulating blood fat and reducing blood pressure |
| 06/21/2006 | CN1788790A Extrasin beta-16 for promoting vascularization, tissue regeneration and wound healing |
| 06/21/2006 | CN1788789A Anti-inflammatory action of oxidation type extrasin beta-10 |
| 06/21/2006 | CN1260361C Inhibition of Ii synthesis |
| 06/21/2006 | CN1260360C Lipid kinase |
| 06/21/2006 | CN1260359C High-solublity expressed tricholsanthin mutant and its preparing method |
| 06/21/2006 | CN1260357C Improved anti-IgE antibodies and method of improving polypeptides |
| 06/21/2006 | CN1260249C Protein purification by ion exchange chromatography |
| 06/21/2006 | CN1259925C Process for preparing compound coemzyme medicine and its compound coemzyme medicine and clinical use |
| 06/20/2006 | USRE39138 antibodies used in enzyme-linked immunosorbent assays for detection of low density lipoproteins, immunoglobulins, collagen, serum and urinary peptides or proteins |
| 06/20/2006 | US7064243 Transgenic roundworm for monitoring inhibitors of protein secretion pathways; parasiticides; disease resistant plants |
| 06/20/2006 | US7064217 2-Aminoacetamide derivatives with hydroxy-, phosphonate-, and/or methylene phosphonate substituent; antitumor, anticoagulant, antiproliferative, and wound healing agents |
| 06/20/2006 | US7064211 Hemiasterlin derivatives and uses thereof |
| 06/20/2006 | US7064195 Fusion proteins of mycobacterium tuberculosis antigens and their uses |
| 06/20/2006 | US7064193 Therapeutic molecules |
| 06/20/2006 | US7064190 An isolated complex of a peptide of glutamic acid decarboxylase(with specific 6 contiguous amino acids), and an allele of MHC class II molecules DR3 and DR4; useful for diagnosis and therapy of autoimmune diseases |
| 06/20/2006 | US7064187 Removing a portion of non-human animal's collagen containing material, washing in saline and alcohol; subjecting material to cellular disruption treatment; digesting the material with a proteoglycan-depleting factor and/or glycosidase |
| 06/20/2006 | US7064186 Comprises chemokine polypeptides for diagnosis, prevention and treatment of cell proliferative, immunological and hematopoietic disorders |
| 06/20/2006 | US7064185 Antibody for human Cyr61 |
| 06/20/2006 | US7064181 A nonapeptide containing an amino acid sequence: ala, pro, ala, his, arg, gly, arg, gly, gly, amide, ester or salt; ability to bind to a receptor protein of specific sequence |
| 06/20/2006 | US7064180 High affinity integrin polypeptides and uses thereof |
| 06/20/2006 | US7064145 Inhibition of beta cell degeneration |
| 06/20/2006 | US7064121 benzodiazepine derivatives that may be fused to a pyrroline or piperidine ring; e.g., N-[1 (R)-(3-Aminopropylcarbamoyl)-2-(naphthalen-2-yl)ethyl]-3-(5,11-dioxo-2,3-dihydro-1H-(11aS)-pyrrolo[2,1-c][1,4]benzodiazepin-10-yl)propionamide; increasing levels of endogenous growth hormones in humans and animals |
| 06/20/2006 | US7064107 Prevention and reduction of blood loss |
| 06/20/2006 | US7064106 Protein, as a reagent for screening a compound that inhibit the binding of the protein to insulin responsive aminopeptidase or to glucose transporter 4; useful as a preventive/remedy for hyperglycemia and diabetes melliuts etc. |
| 06/20/2006 | US7064105 Deoxo-proline-containing tamandarin and didemnin analogs, dehydro-proline-containing tamandarin and didemnin analogs, and methods of making and using them |
| 06/20/2006 | US7064104 Methods of managing the symptoms of premenstrual syndrome |
| 06/20/2006 | US7064103 Quantitative analysis; detecting binding of glucose; diabetes diagnosis |
| 06/20/2006 | US7063973 HDAC9 polypeptides and polynucleotides and uses thereof |
| 06/20/2006 | US7063971 Phosphodiesterase enzymes |
| 06/20/2006 | US7063964 Nucleic acids encoding IL-12 antibody |
| 06/20/2006 | US7063961 Having enhanced affinity for the ErbB-3 and ErbB-4 receptors; enhancing survival, proliferation, of differentiation cells. |
| 06/20/2006 | US7063960 Interacting the immature dendritic cels with an antigen ex vivo so that the surface antigen is presented; inducing maturation ex vivo; and contacting with a modulator comprising TRANCE or derivative |
| 06/20/2006 | US7063959 nucleic acids encoding SOC/CRAC calcium channel polypeptides that play an important role in the influx of extracellular calcium by mediating the refilling of intracellular calcium stores following their depletion |
| 06/20/2006 | US7063958 that encode a receptor for leptin, including a naturally occurring soluble form of the receptor that is expected to modulate, especially agonize, leptin activity; could be used to treat obesity |
| 06/20/2006 | US7063954 Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors |
| 06/20/2006 | US7063865 Mixture of glycine, glutathione, vitamins and minerals; hangover therapy |
| 06/20/2006 | US7063854 Polypeptide comprising the immunogenic portion of wilms' tumor suppressor gene(wt1); tumor-associated antigen for use in cancer immunotherapy |
| 06/20/2006 | US7063850 Protective antigen of group A Streptococci |
| 06/20/2006 | US7063847 Compositions and methods for enhancing immune responses mediated by antigen-presenting cells |
| 06/20/2006 | US7063843 Cloning and regulation of an endothelial cell protein C/activated protein C receptor |
| 06/20/2006 | US7063842 Compounds and methods for inhibiting the interaction between α-catenin and β-catenin |
| 06/20/2006 | US7063840 Genes for receptor tyrosine kinases and their cognate ligands, their insertion into genetic engineered DNA vectors; useful in the diagnosis and treatment of neoplastic diseases |
| 06/20/2006 | US7063838 Methods for treating an artery or vein in a human subject |
| 06/20/2006 | US7063837 Parenteral introduction of at least one lytic enzyme produced by a bacteria infected with a bacteriophage specific for that bacteria and an appropriate carrier for delivering the lytic enzyme into a patient |
| 06/20/2006 | US7063835 Virus strains |
| 06/20/2006 | US7063829 Wasp family protein fragments, and use thereof |
| 06/20/2006 | CA2379633C Amino substituted pyrazolo[1,5,-a]-1,5-pyrimidines and pyrazolo[1,5-a]-1,3,5-triazines |
| 06/20/2006 | CA2260423C Pharmaceutical composition of hedgehog proteins and use thereof |
| 06/15/2006 | WO2006063301A1 Genetically modified tumor cells as cancer vaccines |
| 06/15/2006 | WO2006063168A2 Oxytocin receptor antagonists and their use for the treatment of pulmonary related diseases |
| 06/15/2006 | WO2006063154A1 Composition for proteasome inhibition |
| 06/15/2006 | WO2006063149A1 Nucleosides with antiviral and anticancer activity |
| 06/15/2006 | WO2006063135A2 Tubulin isotype screnning in cancer therapy using hemiasterlin analogs |
| 06/15/2006 | WO2006063132A2 Methods for improving the structure and function of arterioles |
| 06/15/2006 | WO2006062935A2 Methods of reducing the incidence of rejection in tissue transplantation through the prophylactic use of recombinant human antihrombin |
| 06/15/2006 | WO2006062685A2 Novel peptides that bind to the erythropoietin receptor |
| 06/15/2006 | WO2006062559A2 Device for enhancing tissue glucose processing |
| 06/15/2006 | WO2006062422A1 Glyponectin (glycosylated adiponectin) for the treatment of diseases and conditions |
| 06/15/2006 | WO2006062402A2 Heat shock proteins (hsp) and supraventricular arrhythmia |
| 06/15/2006 | WO2006062173A1 Bcl-xL HETERODIMER INHIBITORY PEPTIDE ENHANCING THE EFFECT OF ANTICANCER AGENT AND METHOD OF SCREENING THE SAME |
| 06/15/2006 | WO2006062094A1 Novel cancer antigen peptide and the use thereof |
| 06/15/2006 | WO2006062087A1 Composition for treating or preventing myocardial disorder or heart failure |
| 06/15/2006 | WO2006061714A2 Anticoronaviral compounds and compositions, their pharmaceutical uses and materials for their synthesis |
| 06/15/2006 | WO2006061650A2 Methods, products and uses involving platelets and/or the vasculature |